PATENT CLAIM ANALYSIS

Application Number: 16029228
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "211000"]

Abstract:
The present invention provides a compound of formula I having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.

Claim (Index 11):
A compound of formula I according to any of  claims 1 - 9  for use as therapeutically active substance.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 95.0
- Lexical Diversity: 1.275
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15314718', '15105725', '15502044', '14400448', '13467085']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8287496427323596
- 35 USC 102 Novelty (BERT): 0.5641773859574891
- Combined Prediction Score: 0.8022924170548726
- Mean Citation Score: 422.914858
- Max Citation Score: 521.9717
- Similarity Product: 315.1331287036538

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test